Furthermore, we show that STIM1-KD increases the susceptibility of thyroid cancer ML-1 cells to drugs used for treatment of thyroid cancer, reinstates the expression of thyroid stimulating hormone receptor (TSHR), thyroid specific proteins and increased iodine uptake. The gene discussed is TSHR; the disease is thyroid gland carcinoma.